• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桥接放疗与免疫治疗:IFN-JAK-STAT 轴。

Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis.

机构信息

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

出版信息

Int J Mol Sci. 2021 Nov 14;22(22):12295. doi: 10.3390/ijms222212295.

DOI:10.3390/ijms222212295
PMID:34830176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619591/
Abstract

The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicate cancer. This instills strong interests in understanding the immunomodulatory effects of radiotherapy (RT), an area that was actually investigated more than a century ago but had been largely ignored for many decades. With the "newly" discovered immunogenic responses from RT, numerous endeavors have been undertaken to combine RT with IOs, in order to bolster anti-tumor immunity. However, the underlying mechanisms are not well defined, which is a subject of much investigation. We therefore conducted a systematic literature search on the molecular underpinnings of RT-induced immunomodulation and IOs, which identified the IFN-JAK-STAT pathway as a major regulator. Our further analysis of relevant studies revealed that the signaling strength and duration of this pathway in response to RT and IOs may determine eventual immunological outcomes. We propose that strategic targeting of this axis can boost the immunostimulatory effects of RT and radiosensitizing effects of IOs, thereby promoting the efficacy of combination therapy of RT and IOs.

摘要

免疫疗法(IOs)包括免疫检查点抑制剂(ICBs)和过继性 T 细胞疗法(ACT)在晚期癌症患者中的前所未有的成功提供了原则性证据,即利用免疫系统,特别是 T 细胞,可以成为消除癌症的有效方法。这激发了人们强烈的兴趣,希望了解放疗(RT)的免疫调节作用,这一领域实际上早在一个多世纪前就已经进行了研究,但在几十年的时间里,这一领域基本被忽视了。随着 RT 产生的“新发现”的免疫原性反应,人们已经进行了许多尝试,将 RT 与 IOs 相结合,以增强抗肿瘤免疫力。然而,其潜在的机制尚未明确,这是一个需要大量研究的课题。因此,我们对 RT 诱导的免疫调节和 IOs 的分子基础进行了系统的文献检索,确定 IFN-JAK-STAT 途径是主要的调节途径。我们对相关研究的进一步分析表明,该途径对 RT 和 IOs 的反应的信号强度和持续时间可能决定最终的免疫结果。我们提出,靶向该轴可以增强 RT 的免疫刺激作用和 IOs 的放射增敏作用,从而促进 RT 和 IOs 联合治疗的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/c5ec19fcfa5c/ijms-22-12295-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/2fc60af30c40/ijms-22-12295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/3c4ee0639f21/ijms-22-12295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/c5ec19fcfa5c/ijms-22-12295-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/2fc60af30c40/ijms-22-12295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/3c4ee0639f21/ijms-22-12295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb8c/8619591/c5ec19fcfa5c/ijms-22-12295-g003.jpg

相似文献

1
Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis.桥接放疗与免疫治疗:IFN-JAK-STAT 轴。
Int J Mol Sci. 2021 Nov 14;22(22):12295. doi: 10.3390/ijms222212295.
2
Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.通过细胞质转导肽递送 Tapasin 修饰的 CTL 表位肽通过 JAK/STAT 信号通路在体内诱导 CTL。
Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):181-190. doi: 10.1093/abbs/gmx133.
3
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.Jak-Stat信号传导与癌症:靶向抑制的机遇、益处及副作用
Mol Cell Endocrinol. 2017 Aug 15;451:1-14. doi: 10.1016/j.mce.2017.05.033. Epub 2017 May 30.
4
JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.JAK 和 STAT 信号分子在免疫调节和免疫介导的疾病中的作用。
Immunity. 2012 Apr 20;36(4):542-50. doi: 10.1016/j.immuni.2012.03.014.
5
The interferon signaling network and transcription factor C/EBP-beta.干扰素信号网络与转录因子C/EBP-β
Cell Mol Immunol. 2007 Dec;4(6):407-18.
6
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.靶向 T 细胞淋巴增生性疾病的 JAK/STAT 通路。
Curr Hematol Malig Rep. 2019 Dec;14(6):570-576. doi: 10.1007/s11899-019-00545-5.
7
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.JAK/STAT 多面手:将炎症与癌症发生、肿瘤进展和治疗抵抗联系起来。
Carcinogenesis. 2021 Dec 31;42(12):1411-1419. doi: 10.1093/carcin/bgab075.
8
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.JAK/STAT 信号通路在炎症性肠病发病机制中的作用。
Pharmacol Res. 2013 Oct;76:1-8. doi: 10.1016/j.phrs.2013.06.007. Epub 2013 Jul 2.
9
IL-27 Promotes Human Placenta-Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4IL-10IFN-γ T Cells via the JAK/STAT Pathway in the Treatment of Experimental Graft-versus-Host Disease.IL-27 通过 JAK/STAT 通路促进人胎盘来源间充质干细胞诱导 CD4IL-10IFN-γ T 细胞生成,用于治疗实验性移植物抗宿主病。
J Immunol. 2019 Feb 15;202(4):1124-1136. doi: 10.4049/jimmunol.1800963. Epub 2019 Jan 16.
10
Microarray approach reveals the relevance of interferon signaling pathways with rat liver restoration post 2/3 hepatectomy at cellular level.微阵列分析揭示了细胞水平上干扰素信号通路与大鼠肝 2/3 切除后肝再生的相关性。
J Interferon Cytokine Res. 2010 Jul;30(7):525-39. doi: 10.1089/jir.2009.0111.

引用本文的文献

1
Interferon in Liver Diseases: Recent Advances.肝脏疾病中的干扰素:最新进展
Adv Ther. 2025 Jul 17. doi: 10.1007/s12325-025-03291-8.
2
Viperin: A Multifunctional Protein in Antiviral Immunity and Disease Pathogenesis.蝰蛇毒蛋白:抗病毒免疫与疾病发病机制中的一种多功能蛋白。
Pathogens. 2025 May 21;14(5):510. doi: 10.3390/pathogens14050510.
3
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer.食管癌演变过程中CDKN2A及其他9p21基因缺失的情境依赖性效应。

本文引用的文献

1
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.JAK/STAT 多面手:将炎症与癌症发生、肿瘤进展和治疗抵抗联系起来。
Carcinogenesis. 2021 Dec 31;42(12):1411-1419. doi: 10.1093/carcin/bgab075.
2
IFN-γ-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells.IFN-γ 诱导的内质网应激会损害肺癌细胞中的自噬并引发细胞凋亡。
Oncoimmunology. 2021 Aug 10;10(1):1962591. doi: 10.1080/2162402X.2021.1962591. eCollection 2021.
3
Regulation of CD47 expression by interferon-gamma in cancer cells.
Nat Cancer. 2025 Jan;6(1):158-174. doi: 10.1038/s43018-024-00876-0. Epub 2025 Jan 3.
4
TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal Adenocarcinoma.TGFB2 mRNA 水平与干扰素-α受体激活的 IRF9 和 IFI27 以及免疫检查点 LGALS9 相互作用,影响胰腺导管腺癌的总生存。
Int J Mol Sci. 2024 Oct 18;25(20):11221. doi: 10.3390/ijms252011221.
5
Epigenetic modification in radiotherapy and immunotherapy for cancers.癌症放疗和免疫治疗中的表观遗传修饰
Tzu Chi Med J. 2024 Sep 5;36(4):396-406. doi: 10.4103/tcmj.tcmj_3_24. eCollection 2024 Oct-Dec.
6
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).针对 Hippo 通路以预防来自肺部的放射性耐药脑转移 (综述)。
Int J Oncol. 2024 Jul;65(1). doi: 10.3892/ijo.2024.5656. Epub 2024 May 24.
7
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors.一项探索 'R-ISV-RO' 治疗晚期肿瘤的疗效和安全性的单中心、二期临床试验设计。
Future Oncol. 2024;20(17):1139-1149. doi: 10.2217/fon-2023-0962. Epub 2024 Mar 6.
8
Cellular RNA and DNA sensing pathways are essential for the dose-dependent response of human monocytes to ionizing radiation.细胞 RNA 和 DNA 感应途径是人类单核细胞对电离辐射剂量依赖性反应所必需的。
Front Immunol. 2023 Dec 12;14:1235936. doi: 10.3389/fimmu.2023.1235936. eCollection 2023.
9
Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development.长链非编码RNA与结直肠癌发生发展中的JAK/STAT信号通路调控
Front Genet. 2023 Nov 29;14:1297093. doi: 10.3389/fgene.2023.1297093. eCollection 2023.
10
Virus interference in CoViD-19.新冠病毒中的病毒干扰
Bioinformation. 2022 Sep 30;18(9):768-773. doi: 10.6026/97320630018768. eCollection 2022.
干扰素-γ对癌细胞中CD47表达的调控。
Transl Oncol. 2021 Sep;14(9):101162. doi: 10.1016/j.tranon.2021.101162. Epub 2021 Jun 23.
4
Radiation Resistance: A Matter of Transcription Factors.辐射抗性:转录因子的问题
Front Oncol. 2021 Jun 1;11:662840. doi: 10.3389/fonc.2021.662840. eCollection 2021.
5
Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy.膀胱癌中的性激素受体信号:增强常规非手术治疗效果的潜在靶点。
Cells. 2021 May 11;10(5):1169. doi: 10.3390/cells10051169.
6
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies.Notch、Hedgehog和Wnt信号通路在肿瘤对抗癌治疗耐药性中的作用
Front Cell Dev Biol. 2021 Apr 22;9:650772. doi: 10.3389/fcell.2021.650772. eCollection 2021.
7
IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins.IRF1 通过干扰素诱导蛋白调节结直肠癌的进展。
Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4937. Epub 2021 Apr 28.
8
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance.致癌性 Ras 与野生型 p53 之间的合作会非细胞自主地刺激 STAT,从而促进肿瘤的放射抗性。
Commun Biol. 2021 Mar 19;4(1):374. doi: 10.1038/s42003-021-01898-5.
9
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.干扰素-γ 通过促进 YAP 相分离诱导肿瘤对抗 PD-1 免疫治疗产生耐药性。
Mol Cell. 2021 Mar 18;81(6):1216-1230.e9. doi: 10.1016/j.molcel.2021.01.010. Epub 2021 Feb 18.
10
Targeting the JAK/STAT pathway in solid tumors.针对实体瘤中的JAK/STAT信号通路。
J Cancer Metastasis Treat. 2020;6. Epub 2020 Aug 21.